TNF and heart failure: Anti-inflammatory based-therapies may offer a more attractive target compared to pro-inflammatory cytokine antagonists such as anti-TNF-α treatment, which have failed to show benefits in clinical trials in heart failure patients, likely due to TNF-α’s pleiotropic nature (Chung et al., 2003; Mann et al., 2004).